Chalcones, inhibitors for topoisomerase i and cathepsin B and L, as potential anti-cancer agents
In order to diversify the pharmacological activity of chalcones and extend the scaffold of topoisomerase and cathepsins B and L inhibitors, we have designed and synthesized total 18 chalcone compounds and tested their biological activity. In the topoisome
Kim, Seok-Ho,Lee, Eunyoung,Baek, Kyung Hye,Kwon, Han Byeol,Woo, Hyunjung,Lee, Eung-Seok,Kwon, Youngjoo,Na, Younghwa
p. 3320 - 3324
(2013/06/27)
More Articles about upstream products of 1006268-64-9